ANAMAY BIOTECH already markets a wide range of biotherapeutics

  • Diabetic foot ulcers
  • Venous leg ulcers
  • Bed sores
  • 1st & 2nd degree burns
  • Donor site skin grafts

New Generation biotherapeutics with applied Recombinant Technology

REGEN-D ® 60

  • REGEN-D® 60 (Recombinant Human Epidermal Growth Factor) is indicated for 1st & 2nd degree burns & donor site skin grafts
  • Reduces wound healing time by 50%
  • Quick & scarless healing

REGEN-D ® 150

  • REGEN-D 150® (Recombinant Human Epidermal Growth Factor) is a new generation therapy for diabetic foot ulcers, bed sores & venous leg ulcers
  • Reduces wound healing time by 50%
  • Prevents limb amputation

SLVRGEN ®

  • SLVRGEN® is a novel synergistic formulation for treatment of 1st & 2nd degree burns
  • SLVRGEN® negates silver toxicity, prevents infection & shows faster healing activity